ES8101855A1 - Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina - Google Patents

Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina

Info

Publication number
ES8101855A1
ES8101855A1 ES486157A ES486157A ES8101855A1 ES 8101855 A1 ES8101855 A1 ES 8101855A1 ES 486157 A ES486157 A ES 486157A ES 486157 A ES486157 A ES 486157A ES 8101855 A1 ES8101855 A1 ES 8101855A1
Authority
ES
Spain
Prior art keywords
water
preparation
colloidal aqueous
pharmacy
dihexanoil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES486157A
Other languages
English (en)
Spanish (es)
Other versions
ES486157A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES486157A0 publication Critical patent/ES486157A0/es
Publication of ES8101855A1 publication Critical patent/ES8101855A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES486157A 1978-11-21 1979-11-20 Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina Expired ES8101855A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1192178 1978-11-21

Publications (2)

Publication Number Publication Date
ES486157A0 ES486157A0 (es) 1981-01-16
ES8101855A1 true ES8101855A1 (es) 1981-01-16

Family

ID=4378189

Family Applications (1)

Application Number Title Priority Date Filing Date
ES486157A Expired ES8101855A1 (es) 1978-11-21 1979-11-20 Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina

Country Status (22)

Country Link
US (1) US4271196A (cg-RX-API-DMAC10.html)
EP (1) EP0011745B1 (cg-RX-API-DMAC10.html)
JP (1) JPS5572111A (cg-RX-API-DMAC10.html)
KR (1) KR850000584B1 (cg-RX-API-DMAC10.html)
AR (1) AR225294A1 (cg-RX-API-DMAC10.html)
AT (1) ATE501T1 (cg-RX-API-DMAC10.html)
AU (1) AU529061B2 (cg-RX-API-DMAC10.html)
CA (1) CA1136988A (cg-RX-API-DMAC10.html)
DE (1) DE2961718D1 (cg-RX-API-DMAC10.html)
DK (1) DK494079A (cg-RX-API-DMAC10.html)
ES (1) ES8101855A1 (cg-RX-API-DMAC10.html)
FI (1) FI793461A7 (cg-RX-API-DMAC10.html)
GR (1) GR73668B (cg-RX-API-DMAC10.html)
HU (1) HU180792B (cg-RX-API-DMAC10.html)
IE (1) IE48659B1 (cg-RX-API-DMAC10.html)
IL (1) IL58723A (cg-RX-API-DMAC10.html)
MC (1) MC1297A1 (cg-RX-API-DMAC10.html)
NO (1) NO793759L (cg-RX-API-DMAC10.html)
NZ (1) NZ192118A (cg-RX-API-DMAC10.html)
PH (1) PH15561A (cg-RX-API-DMAC10.html)
PT (1) PT70478A (cg-RX-API-DMAC10.html)
ZA (1) ZA796116B (cg-RX-API-DMAC10.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
US4457918A (en) * 1982-05-12 1984-07-03 The General Hospital Corporation Glycosides of vitamins A, E and K
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US4891208A (en) * 1985-04-10 1990-01-02 The Liposome Company, Inc. Steroidal liposomes
US5231112A (en) 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
ES2206473T3 (es) * 1994-05-20 2004-05-16 Gesellschaft Fur Medizinische Forschung Und Weiterbildung E.V. Gmf Emulsion de aceite en agua que contiene lormetazepam.
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
KR100508910B1 (ko) 1995-10-17 2006-04-20 알티피 파마 코포레이션 불용성약물방출
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
CN1289091C (zh) * 1998-02-11 2006-12-13 Rtp药品公司 治疗炎症的药物组合物和相关用途
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
KR100635456B1 (ko) 1998-05-29 2006-10-18 스키에파마 캐나다 인코포레이티드 열보호화 마이크로입자 조성물 및 그의 말단의 스팀멸균방법
EP1105096B1 (en) 1998-08-19 2003-10-29 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
KR20010073232A (ko) 1998-11-20 2001-07-31 추후제출 분산성 인지질로 안정화된 마이크로입자
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
JP2003509453A (ja) * 1999-09-21 2003-03-11 アールティーピー・ファーマ・インコーポレーテッド 生物学的に活性な物質の、表面改質された粒状組成物
HK1053786A1 (zh) 2000-04-20 2003-11-07 Rtp Pharma Inc. 改进的水不溶的药物颗粒工艺
ES2325057T3 (es) 2000-08-31 2009-08-25 Jagotec Ag Particulas molturadas.
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
JP2004509146A (ja) * 2000-09-20 2004-03-25 スカイファーマ・カナダ・インコーポレーテッド 安定化フィブレート微粒子
PL202778B1 (pl) * 2001-02-22 2009-07-31 Skyepharma Canada Inc Postać dawkowana kombinacji statyny i fenofibratu, sposób jej wytwarzania i zastosowanie
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU29060A1 (cg-RX-API-DMAC10.html) *
LU28584A1 (cg-RX-API-DMAC10.html) *
FR2102537A5 (cg-RX-API-DMAC10.html) * 1970-08-07 1972-04-07 Ugine Kuhlmann
FR2270887A1 (en) * 1974-05-16 1975-12-12 Chabrier De Lassauniere Pierre Prepn of lecithins and glycol-lecithins - by reaction of trimethylamine with 2-substd-2-oxo-1,3,2-dioxaphospholans
SE442014B (sv) * 1976-10-12 1985-11-25 Barry D Sears Syntetisk fosfatidyl-kvarter ammoniumforening till anvendning for solubilisering eller emulgering av vattenolosliga foreningar

Also Published As

Publication number Publication date
NZ192118A (en) 1981-12-15
ES486157A0 (es) 1981-01-16
ZA796116B (en) 1980-11-26
IE792216L (en) 1980-05-21
PT70478A (en) 1979-12-01
JPS5572111A (en) 1980-05-30
IL58723A0 (en) 1980-02-29
AU529061B2 (en) 1983-05-26
AR225294A1 (es) 1982-03-15
CA1136988A (en) 1982-12-07
KR850000584B1 (ko) 1985-04-30
GR73668B (cg-RX-API-DMAC10.html) 1984-03-28
DE2961718D1 (en) 1982-02-18
ATE501T1 (de) 1982-01-15
EP0011745B1 (de) 1981-12-30
JPH0122243B2 (cg-RX-API-DMAC10.html) 1989-04-25
MC1297A1 (fr) 1980-10-03
US4271196A (en) 1981-06-02
AU5282479A (en) 1980-05-29
NO793759L (no) 1980-05-22
IE48659B1 (en) 1985-04-03
PH15561A (en) 1983-02-11
FI793461A7 (fi) 1981-01-01
IL58723A (en) 1982-11-30
EP0011745A1 (de) 1980-06-11
DK494079A (da) 1980-05-22
HU180792B (en) 1983-04-29

Similar Documents

Publication Publication Date Title
ES8101855A1 (es) Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
NO153637C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat som er egnet for transdermal administrering av virkestoffer.
ES8308698A1 (es) Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos
CA2027592A1 (en) Solid pharmaceutical preparations of active form of vitamin d_ of improved stability
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
JPS51148013A (en) Stable insulin preparation for nosal administration
ES8101537A1 (es) Un procedimiento para preparar nuevas fenetanolaminas
KR910005858A (ko) 지방산 요법
JPS5218813A (en) Plasters for the relief of cutaneous diseases
Eisenberger Supporting evidence for an active treatment program for advanced salivary gland carcinomas
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
Fischer et al. Severe contact dermatitis due to nitroglycerin patches
ES526300A0 (es) Procedimiento para la obtencion de una composicion farmaceutica conteniendo un agente fibrino litico y un factor de difusion, util para el tratamiento del infarto de miocardio.
AU1417388A (en) Pharmaceutical preparation
ATE35620T1 (de) Pharmazeutische zubereitung mit retardwirkung.
ES495831A0 (es) Procedimiento para la obtencion de esteres 4,5-dialquil-3- hidroxi-pirrol-2-carboxilicos
IT7921958A0 (it) Agente per attirare insetti composito, per i maschi della nottua del cavolo e procedimento per preparare i suoi principi attivi.
FR2336121A1 (fr) Nouveau procede de preparation de produits cosmetiques d'origine foetale, et produits obtenus
AU4831279A (en) New compounds
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
KR880002521A (ko) 약제 제형
GB1125924A (en) Organic bismuth derivative